2024 exceptional surveillance of familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer (NICE guideline CG164)

In July 2024, we reviewed this guideline in response to several changes which impact on the recommendations, most notably, assessment of familial breast cancer and genetic testing.

Surveillance decision

The guideline will be updated to reflect these changes in practice. 

More information is available on the web page for NICE’s prioritisation decisions. 


This page was last updated: